PGHL vs WOCKPHARMA: Stock Comparison

PROCTER & GAMBLE HEALTH L vs WOCKHARDTUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

WOCKHARDT is the larger company by market capitalisation. PROCTER & GAMBLE HEALTH L shows a lower P/E, a higher ROE and a higher dividend yield, while WOCKHARDT shows faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

PGHL leads 9; WOCKPHARMA leads 4 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

PGHLWOCKPHARMA

Valuation lens

What price are you paying?

Market CapContext only
₹9,379 Cr
₹33,908 Cr
P/E RatioPGHL has the lower reading
26.43x
75.68x
P/B RatioWOCKPHARMA has the lower reading
17.98x
6.27x
EPSPGHL has the higher reading
₹57.92
₹6.58
Book ValueContext only
₹316.01
₹325
Dividend YieldPGHL has the higher reading
3.45%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
WOCKPHARMA is the larger company
₹33,908 Cr vs ₹9,379 Cr
P/E Ratio
PGHL has a lower P/E
26.43x vs 75.68x
P/B Ratio
WOCKPHARMA has a lower P/B
6.27x vs 17.98x
EPS
PGHL has higher earnings per share
₹57.92 vs ₹6.58
Dividend Yield
PGHL has a higher dividend yield
3.45% vs 0%
Revenue Growth (TTM YoY)
WOCKPHARMA has faster revenue growth
26% vs 19.1%
EPS Growth (TTM YoY)
PGHL has faster EPS growth
54.6% vs 0%
Qtr Sales Growth
WOCKPHARMA has stronger quarterly sales growth
-39.61% vs -74.17%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricPGHLWOCKPHARMA
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricPGHLWOCKPHARMA
Live Price₹5,660₹2,088.7
Day Change-1.69%7.08%
Volume7,25535.58 L
52-Week High₹6,975₹2,422.3
52-Week Low₹4,707₹1,086.7
Distance from 52W High-18.85%-13.77%

Valuation

MetricPGHLWOCKPHARMA
Market Cap₹9,379 Cr₹33,908 Cr
P/E Ratio26.43x75.68x
P/B Ratio17.98x6.27x
EPS₹57.92₹6.58
Book Value₹316.01₹325
Dividend Yield3.45%0%

Growth

MetricPGHLWOCKPHARMA
Revenue Growth (TTM YoY)19.1%26%
EPS Growth (TTM YoY)54.6%0%
Qtr Sales Growth-74.17%-39.61%
Qtr Profit Growth-70.59%0%

Profitability & Leverage

MetricPGHLWOCKPHARMA
ROE62.32%10.28%
ROCE92.1%10.37%
Net Margin23.22%3.3%
Operating Margin31.99%28.35%
Debt to Equity0x0.57x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricPGHLWOCKPHARMA
Promoter Holding0%49.08%
FII Holding6.33% 0.13 pp7.22% 0.13 pp
DII Holding12.44% 1.23 pp9.24% 1.72 pp
Public Holding29.42% 1.11 pp34.44% 1.61 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: PROCTER & GAMBLE HEALTH L and WOCKHARDT.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.